Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Opyl Ltd. ( (AU:PKY) ) has provided an update.
Pathkey.AI Ltd has announced that its Annual General Meeting (AGM) will take place on November 26, 2025, with the re-election of Directors as a key agenda item. The deadline for director nominations is set for October 8, 2025. This meeting is crucial for the company’s governance and strategic direction, impacting its operations and stakeholder engagement.
More about Opyl Ltd.
Pathkey.AI Limited is an Australian technology company specializing in artificial intelligence solutions to enhance the efficiency, success, and transparency of clinical trials. Their core platform, TrialKey, is an AI-powered decision-support tool designed to predict the success probability of clinical trials and optimize trial design and planning. The company aims to transform drug development by reducing risk, improving resource allocation, and fostering data-driven innovation in the life sciences sector.
Average Trading Volume: 895,897
Technical Sentiment Signal: Hold
Current Market Cap: A$7.87M
See more data about PKY stock on TipRanks’ Stock Analysis page.